<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04244643</url>
  </required_header>
  <id_info>
    <org_study_id>IRBN922019/CHUSTE</org_study_id>
    <nct_id>NCT04244643</nct_id>
  </id_info>
  <brief_title>Ocular Surface in Patients With Soft Contact Lenses</brief_title>
  <acronym>E2LC</acronym>
  <official_title>Ocular Surface in Patients With Soft Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Société Française des Ophtalmologistes Adaptateurs de Lentilles de Contact</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contact lenses modify the structure of the tear film by biophysical and biochemical
      interactions. These changes may explain more common dry eye symptoms and may sometimes cause
      lens failure or discontinuation.

      In recent years, the investigators have various objective non-invasive methods of tear film
      evaluation such as the non-invasive break up time, interferometry, and tears meniscus height.
      These measurements are performed in clinical practice during consultation by devices such as
      LACRYDIAG.

      The improvement of lens comfort requires a better knowledge of the ocular surface in patients
      with contact lenses. But currently none of these objective parameters have been accurately
      described.

      Therefore, the investigators would like to build a database to describe the different
      parameters of ocular surface in patients with soft contact lenses.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 18, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>eye surface condition</measure>
    <time_frame>baseline</time_frame>
    <description>presence or not : dry eye, allergies, blepharitis, corneal abscess, corneal ulceration, corneal neovascularization, chronic inflammatory conjunctivitis and others</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>refraction</measure>
    <time_frame>baseline</time_frame>
    <description>measured with vision tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ocular Surface Disease Index score</measure>
    <time_frame>baseline</time_frame>
    <description>is a 12-item questionnaire designed to provide a rapid assessment of the symptoms of ocular irritation consistent with dry eye disease and their impact on vision-related functioning.
The overall OSDI score defined the ocular surface as normal (0-12 points) or as having mild (13-22 points), moderate (23-32 points), or severe (33-100 points) disease.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>non-invasive tear break-up time</measure>
    <time_frame>baseline</time_frame>
    <description>with LACRYDIAG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>interferometry</measure>
    <time_frame>baseline</time_frame>
    <description>with LACRYDIAG. Qualitative &amp; quantitative analysis of the lipid layer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tears meniscus height</measure>
    <time_frame>baseline</time_frame>
    <description>with LACRYDIAG</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Ocular Surface</condition>
  <arm_group>
    <arm_group_label>Patients with soft contact lenses</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>data collection</intervention_name>
    <description>Data collected from patient records
Demographic data: date of birth, sex, city of birth
Contact lenses: laboratory, brand, model, wearing time before the exam, opening date of the blister, solution of contact lenses, material, renewal time
Refraction
Dry eye disease: Ocular Surface Disease Index (OSDI) score
LACRYDIAG data: Non-Invasive Break-Up Time (NIBUT), interferometry and tears meniscus height</description>
    <arm_group_label>Patients with soft contact lenses</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with soft contact lenses
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with soft contact lenses

          -  Patients with their contact lenses on the eyes at the time of the examination and
             having undergone a LACRYDIAG examination

          -  Only Right eye analyze

        Exclusion Criteria:

          -  Patients with rigid contact lenses

          -  Patients not wearing their lenses at the time of the examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie Caroline TRONE</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marie Caroline TRONE</last_name>
    <phone>04 77 82 94 28</phone>
    <phone_ext>+33</phone_ext>
    <email>m.caroline.trone@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie PEURIERE</last_name>
    <phone>04 77 82 92 72</phone>
    <phone_ext>+33</phone_ext>
    <email>marie.peuriere@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cabinet médico-chirurgical de l'Alcazar</name>
      <address>
        <city>Beausoleil</city>
        <zip>06240</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie ELMALEH, MD</last_name>
    </contact>
    <investigator>
      <last_name>Valérie ELMALEH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr Virginie MADARIAGA</name>
      <address>
        <city>Blagnac</city>
        <zip>31700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie MADARIAGA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Virginie MADARIAGA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Point Vision Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence MALET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Florence MALET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr Françoise LE CHERPIE</name>
      <address>
        <city>Draguignan</city>
        <zip>83300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Françoise LE CHERPIE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Françoise LE CHERPIE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr Hélène Bertrand</name>
      <address>
        <city>Lille</city>
        <zip>59800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène BERTRAND, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hélène BERTRAND, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre ophtalmologique Saint-Paul</name>
      <address>
        <city>Paris</city>
        <zip>75004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurore MUSSELIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Aurore MUSSELIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Point Vision Paris Royale</name>
      <address>
        <city>Paris</city>
        <zip>75008</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine PEYRE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Catherine PEYRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier national d'ophtalmologie des Quinze-Vingts</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliette KNOERI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Juliette KNOERI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr Cyrille TEMSTET</name>
      <address>
        <city>Paris</city>
        <zip>75017</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyrille TEMSTET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Cyrille TEMSTET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Saint Etienne</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Caroline TRONE, MD</last_name>
      <phone>(0)4 77 82 92 72</phone>
      <phone_ext>+33</phone_ext>
      <email>m.caroline.trone@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Marie Caroline TRONE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Point Vision Nice - St Laurent du Var</name>
      <address>
        <city>Saint-Laurent-du-Var</city>
        <zip>06700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louisette BLOISE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Louisette BLOISE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katherine VIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique St Jean Languedoc</name>
      <address>
        <city>Toulouse</city>
        <zip>31400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie MALECAZE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie MALECAZE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>January 15, 2020</study_first_submitted>
  <study_first_submitted_qc>January 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>January 27, 2020</last_update_submitted>
  <last_update_submitted_qc>January 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>contact lenses</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

